New technique protects synthetic gene circuits against cell growth dilution

Genetic engineers can design and assemble sophisticated gene circuits to program cells with new functions, but important ...

Eilean Therapeutics Presents First-in-Class MALT1 Degrader TE205 Demonstrating In Vivo Efficacy in Ulcerative Colitis at the 4th International Conference on Microbiology and ...

Eilean Therapeutics LLC is a biopharmaceutical company focused on the discovery and development of best-in-class and first-in-class small-molecule therapies addressing genetic and signaling ...
Business Wire

Clasp Therapeutics Presents Comprehensive Preclinical Data Validating First-in-Class Precision T Cell Engager Against p53 Mutant Solid Tumors at SITC Annual Meeting

CAMBRIDGE, MA. & ROCKVILLE, MD.--(BUSINESS WIRE)--Clasp Therapeutics, a biotechnology company bringing unparalleled precision to immuno-oncology using next-generation TCEs, today announced new data ...
Healio

Zimislecel, a novel cell therapy, appears to restore islet function in type 1 diabetes

Please provide your email address to receive an email when new articles are posted on . Zimislecel is an investigational stem cell-derived islet therapy for type 1 diabetes. Ten of 12 participants no ...
The Chronicle

The Duke AI tool aiming to uncover the cells behind aging

The AI-based method, DeepScence, works to identify senescent cells in the body. These are cells that have stopped dividing ...

Whole new class of anti-ageing drug found to work at cell level

Scientists have identified a new anti-ageing drug class that works by acting on a key gut bacteria process, an advance that ...